CLINICAL_TRIALS
trial_result
· 2018-11-05
Clinical Trial Update: Pharmacological Treatment of Rett Syndrome With Glatiramer Acetate (Copaxone) [Phase 2]
Summary
Phase 2 trial evaluating glatiramer acetate (Copaxone) for Rett syndrome has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Montefiore Medical Center | Conditions: Rett Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2018-11-05